GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (FRA:LCLA) » Definitions » Cyclically Adjusted PB Ratio

PT Kalbe Farma Tbk (FRA:LCLA) Cyclically Adjusted PB Ratio : 4.10 (As of Jun. 22, 2024)


View and export this data going back to 2004. Start your Free Trial

What is PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio?

As of today (2024-06-22), PT Kalbe Farma Tbk's current share price is €0.082. PT Kalbe Farma Tbk's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €0.02. PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio for today is 4.10.

The historical rank and industry rank for PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:LCLA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.8   Med: 5.62   Max: 7.34
Current: 4.24

During the past years, PT Kalbe Farma Tbk's highest Cyclically Adjusted PB Ratio was 7.34. The lowest was 3.80. And the median was 5.62.

FRA:LCLA's Cyclically Adjusted PB Ratio is ranked worse than
77.69% of 753 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs FRA:LCLA: 4.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PT Kalbe Farma Tbk's adjusted book value per share data for the three months ended in Mar. 2024 was €0.029. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.02 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio Historical Data

The historical data trend for PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.64 5.45 5.55 6.35 4.47

PT Kalbe Farma Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.23 5.96 5.00 4.47 4.00

Competitive Comparison of PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio falls into.



PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.082/0.02
=4.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kalbe Farma Tbk's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, PT Kalbe Farma Tbk's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.029/130.6070*130.6070
=0.029

Current CPI (Mar. 2024) = 130.6070.

PT Kalbe Farma Tbk Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.011 93.015 0.015
201409 0.012 94.576 0.017
201412 0.013 98.819 0.017
201503 0.015 98.388 0.020
201506 0.014 99.766 0.018
201509 0.013 101.037 0.017
201512 0.015 102.133 0.019
201603 0.016 102.764 0.020
201606 0.015 103.212 0.019
201609 0.017 104.142 0.021
201612 0.018 105.222 0.022
201703 0.019 106.476 0.023
201706 0.017 107.722 0.021
201709 0.017 108.020 0.021
201712 0.018 109.017 0.022
201803 0.017 110.097 0.020
201806 0.017 111.085 0.020
201809 0.017 111.135 0.020
201812 0.019 112.430 0.022
201903 0.020 112.829 0.023
201906 0.020 114.730 0.023
201909 0.021 114.905 0.024
201912 0.022 115.486 0.025
202003 0.019 116.252 0.021
202006 0.022 116.630 0.025
202009 0.021 116.397 0.024
202012 0.022 117.318 0.024
202103 0.023 117.840 0.025
202106 0.022 118.184 0.024
202109 0.024 118.262 0.027
202112 0.026 119.516 0.028
202203 0.027 120.948 0.029
202206 0.026 123.322 0.028
202209 0.028 125.298 0.029
202212 0.026 126.098 0.027
202303 0.028 126.953 0.029
202306 0.027 127.663 0.028
202309 0.027 128.151 0.028
202312 0.028 129.395 0.028
202403 0.029 130.607 0.029

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PT Kalbe Farma Tbk  (FRA:LCLA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kalbe Farma Tbk (FRA:LCLA) Business Description

Traded in Other Exchanges
Address
Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510
Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk (FRA:LCLA) Headlines

No Headlines